Literature DB >> 29424336

A novel UMOD gene mutation associated with chronic kidney failure at a young age.

Nicolina Stefania Carucci, Gianluca Caridi, Francesca Lugani, Claudia Barone, Giovanni Conti.   

Abstract

Autosomal dominant tubulointerstitial kidney disease (ADTKD) belongs to a group of renal hereditary disorders linked by common findings of tubulointerstitial disease and dominant inheritance. The renal clinical phenotype is characterized by chronic kidney disease, hyperuricemia, gout, and, inconstantly, renal cysts. Uromodulin (UMOD) gene mutations are related to the clinical phenotype of ADTKD-UMOD. We describe here a novel heterozygous mutation of UMOD (c.249C>G; p.Cys83Trp) in an affected 9-year-old boy with progressive renal impairment and hyperuricemia. His mother is also affected and received renal transplantation at the age of 31 years. We assume that this variant is likely to be the causative mutation in this family as it segregates with the disease, it is not present in the genomic databases, and it is predicted to be damaging by the principal software tools. Considering the progressive renal impairment of our proband at an early age (serum creatinine elevation at the age of 6, hyperuricemia at the age of 9) and the early age at end-stage renal disease of his mother, we hypothesize that this variant is associated with a severe clinical phenotype.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29424336     DOI: 10.5414/CN109128

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  2 in total

Review 1.  Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β.

Authors:  Anthony J Bleyer; Matthias T Wolf; Kendrah O Kidd; Martina Zivna; Stanislav Kmoch
Journal:  Pediatr Nephrol       Date:  2021-05-22       Impact factor: 3.651

2.  Autosomal dominant tubulointerstitial kidney disease with a novel heterozygous missense mutation in the uromodulin gene: A case report.

Authors:  Li-Ling Zhang; Jia-Ru Lin; Ting-Ting Zhu; Qi Liu; Dong-Mei Zhang; Lin-Wang Gan; Ying Li; San-Tao Ou
Journal:  World J Clin Cases       Date:  2021-11-26       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.